Noxopharm Ltd. · ASX:NOX

Boris Patkin received 372,105 Noxopharm Ltd. shares as an award (Appendix 3Y, ASX)

Traded Nov 20, 2026 · Filed Nov 20, 2026

On Nov 20, 2026, Boris Patkin (Director) received 372,105 Noxopharm Ltd. shares as an award at AUD 0.09 for AUD 33,750. Filed Nov 20, 2026 (Appendix 3Y, ASX).

Awarded
372,105 shares
Price
AUD 0.09
Value
AUD 33,750
Role
Director

The filing in full

Appendix 3Y

*Rule 3.19A.2*

Change of Director’s Interest Notice

*Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.*

Introduced 30/09/01 Amended 01/01/11

Name of entityNoxopharm Limited
ABN50 608 966 123

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.

Name of DirectorBoris Patkin
Date of last notice1 June 2026

Part 1 - Change of director’s relevant interests in securities

*In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust*

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.

Direct or indirect interestIndirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.Snowy Plains Pty Ltd, an entity controlled by Boris Patkin.
Date of change20 November 2026
No. of securities held prior to change Snowy Plains Pty Ltd630,000
ClassOrdinary
Number acquired372,105
Number disposedNil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuationThese were issued for non-cash consideration, and issued at $0.0907 per Fully Paid Ordinary Share.
No. of securities held after change1,002,105
  • See chapter 19 for defined terms.

---

Nature of changeExample: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-backShares issued in lieu of Directors’ fees following shareholder approval on 17 November 2026.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.

Detail of contractN/A
Nature of interestN/A
Name of registered holder (if issued securities)N/A
Date of changeN/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changedN/A
Interest acquiredN/A
Interest disposedN/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuationN/A
Interest after changeN/A

+ Part 3 – Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?No
If so, was prior written clearance provided to allow the trade to proceed during this period?N/A
If prior written clearance was provided, on what date was this provided?N/A
  • See chapter 19 for defined terms.
DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 20, 2026OrdinaryAward372,105AUD 0.09

Source

Download PDF · View original at ASX

Related